These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17250545)

  • 21. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment methods for the evaluation of vitiligo.
    Alghamdi KM; Kumar A; Taïeb A; Ezzedine K
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1463-71. PubMed ID: 22416879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo.
    Benzekri L; Gauthier Y; Hamada S; Hassam B
    Br J Dermatol; 2013 Feb; 168(2):265-71. PubMed ID: 22963656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus.
    Taher ZA; Lauzon G; Maguiness S; Dytoc MT
    Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis.
    van Geel N; Grine L; De Wispelaere P; Mertens D; Prinsen CAC; Speeckaert R
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1667-1675. PubMed ID: 31131483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of vitiligo among type 2 diabetic patients in an Iranian population.
    Afkhami-Ardekani M; Ghadiri-Anari A; Ebrahimzadeh-Ardakani M; Zaji N
    Int J Dermatol; 2014 Aug; 53(8):956-8. PubMed ID: 24134629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo: A Review.
    Bergqvist C; Ezzedine K
    Dermatology; 2020; 236(6):571-592. PubMed ID: 32155629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-onset childhood vitiligo is associated with a more extensive and progressive course.
    Mu EW; Cohen BE; Orlow SJ
    J Am Acad Dermatol; 2015 Sep; 73(3):467-70. PubMed ID: 26118892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a New Scoring Tool to Evaluate the Clinical Evolution of Adult Patients with Nonsegmental Vitiligo.
    Peralta-Pedrero ML; Herrera-Bringas D; Torres-González KS; Morales-Sánchez MA; Jurado Santa-Cruz F; Cruz-Avelar A
    Dermatology; 2021; 237(6):952-960. PubMed ID: 33486476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a hand-held black-light source instead of a Wood's lamp.
    Kaliyadan F; Kuruvilla J
    J Am Acad Dermatol; 2015 Jun; 72(6):e153-4. PubMed ID: 25981019
    [No Abstract]   [Full Text] [Related]  

  • 35. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany.
    Radtke MA; Schäfer I; Gajur AI; Augustin M
    Dermatology; 2010; 220(3):194-200. PubMed ID: 20203472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A grayscale photograph with high dynamic range taken under a Wood's lamp for better recognition of vitiligo lesions.
    Bae JM; Han TY
    J Am Acad Dermatol; 2017 Mar; 76(3):e89-e90. PubMed ID: 28212773
    [No Abstract]   [Full Text] [Related]  

  • 38. Using the blue screen of a smartphone as an alternative to Wood's lamp for examination of vitiligo.
    Agrawal S; Sharma A; Dhurat R; Chahal K
    J Am Acad Dermatol; 2023 Jan; 88(1):e5-e6. PubMed ID: 31015013
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
    Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
    Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of vitiligo in the south of Tunisia.
    Akrem J; Baroudi A; Aichi T; Houch F; Hamdaoui MH
    Int J Dermatol; 2008 Jul; 47(7):670-4. PubMed ID: 18613871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.